Across TCGA pan-cancer cohorts, MTRES1P1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MTRES1P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where MTRES1P1 RNA is repressed in tumor relative to normal tissue. In most cancer types MTRES1P1 is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

KIRP are the cancer types where MTRES1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTRES1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	III,IV	−0.035	.010	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MTRES1P1 RNA expression & survival · all MTRES1P1 data types